Adlai Nortye Biopharma
Yiheng Grace Hu has a diverse work experience in the medical field. Most recently, they are employed as a Senior Medical Manager at Adlai Nortye Biopharma Co., Ltd since March 2022. Prior to this, they worked as a Resident Physician at a private hospital in Nanjing from February 2019 to March 2022. During their residency training, they achieved impressive scores on various medical licensing examinations. Yiheng also gained research experience during their time as a Postdoctoral Associate at the University of Pittsburgh from June 2016 to November 2018, at Baylor College of Medicine from March 2015 to May 2016, and at The Ohio State University Wexner Medical Center from June 2014 to March 2015. Yiheng Grace also served as a Graduate Research Associate at The Ohio State University from September 2008 to May 2014.
Yiheng Grace Hu pursued their education at The Ohio State University from 2008 to 2014. During this period, they completed a Doctor of Philosophy (Ph.D.) degree in the field of Molecular, Cellular and Developmental Biology.
This person is not in any offices
Adlai Nortye Biopharma
1 followers
Adlai Nortye Biopharma is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with our R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, they have built a global pipeline through collaborations and internal discovery with more than 10 drug candidates in development. They have assembled a world-class management team, built a unique immuno-oncology platforms and partnered with multiple top pharmaceutical companies to promote innovation.